Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Shares Issued (2016 - 2025)

Capricor Therapeutics has reported Shares Issued over the past 15 years, most recently at $77.5 million for Q4 2025.

  • Quarterly results put Shares Issued at $77.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $77.6 million (changed N/A YoY), and the annual figure for FY2025 was $11.9 million, down 92.21%.
  • Shares Issued for Q4 2025 was $77.5 million at Capricor Therapeutics, up from $6950.0 in the prior quarter.
  • Over the last five years, Shares Issued for CAPR hit a ceiling of $77.5 million in Q4 2025 and a floor of -$27465.0 in Q2 2022.
  • Median Shares Issued over the past 5 years was $4.9 million (2021), compared with a mean of $10.8 million.
  • Biggest five-year swings in Shares Issued: plummeted 103.92% in 2022 and later soared 53258.57% in 2023.
  • Capricor Therapeutics' Shares Issued stood at $7.5 million in 2021, then soared by 65.33% to $12.4 million in 2022, then surged by 33.87% to $16.6 million in 2023, then dropped by 9.64% to $15.0 million in 2024, then skyrocketed by 416.67% to $77.5 million in 2025.
  • The last three reported values for Shares Issued were $77.5 million (Q4 2025), $6950.0 (Q3 2025), and $19580.0 (Q2 2025) per Business Quant data.